CNTN2
contactin 2 (axonal)
CNTN2; contactin 2 (axonal); AXT; TAX; TAX1; FAME5; TAG-1; contactin-2; TAX-1; axonal glycoprotein TAG-1; axonin-1 cell adhesion molecule; transient axonal glycoprotein 1; contactin 2 (transiently expressed); transiently-expressed axonal glycoprotein;
DNAL4
dynein, axonemal, light chain 4
DNAL4; dynein, axonemal, light chain 4; dynein, axonemal, light 4 , dynein, axonemal, light polypeptide 4; dynein light chain 4, axonemal; dJ327J16; PIG27; dynein, axonemal, light 4; proliferation-inducing gene 27; dynein light chain, outer arm 4; prolif;
EXOSC10
Exosome Component 10
EXOSC10; exosome component 10; p3; p4; RRP6; PMSCL; Rrp6p; PM-Scl; PMSCL2; PM/Scl-100; OTTHUMP00000002176; OTTHUMP00000002177; autoantigen PM-SCL; autoantigen PM/Scl 2; polymyositis/scleroderma autoantigen 100 kDa; polymyositis/scleroderma autoantigen 2 (100kD); polymyositis/scleroderma autoantigen 2, 100kDa; P100 polymyositis-scleroderma overlap syndrome-associated autoantigen; EXOSX_HUMAN; p2; PM Scl; PM/Scl 100;
GCK
glucokinase (hexokinase 4)
GCK; glucokinase (hexokinase 4); GK; GLK; HK4; HHF3; HKIV; HXKP; LGLK; MODY2; FGQTL3; glucokinase; HK IV; hexokinase-4; hexokinase-D; hexokinase type IV; hexokinase D, pancreatic isozyme; ATP:D-hexose 6-phosphotransferase;
HK2
hexokinase 2
HK2; hexokinase 2; HKII; HXK2; hexokinase-2; HK II; hexokinase type II; hexokinase-2, muscle; muscle form hexokinase;
HK3
hexokinase 3 (white cell)
HK3; hexokinase 3 (white cell); hexokinase-3; HK III; hexokinase type III; ATP:D-hexose 6-phosphotransferase; HXK3; HKIII;
KHK
ketohexokinase (fructokinase)
KHK; ketohexokinase (fructokinase); ketohexokinase; hepatic fructokinase;
OGG1
8-oxoguanine DNA glycosylase
OGG1; 8-oxoguanine DNA glycosylase; N-glycosylase/DNA lyase; 8 hydroxyguanine DNA glycosylase; HMMH; HOGG1; MUTM; OGG1 type 1d; OGG1 type 1e; OGG1 type 1g; OGG1 type 1h; OGH1; AP lyase; OGG1 type 1f; 8-hydroxyguanine DNA glycosylase; DNA-apurinic or apyri;
PON1
paraoxonase 1
PON1; ESA; MVCD5; PON; A-esterase 1; K-45; PON 1; aromatic esterase 1; arylesterase B-type; esterase A; paraoxonase B-type; serum aryldiakylphosphatase; serum aryldialkylphosphatase 1; serum paraoxonase/arylesterase 1; paraoxonase 1;
PON2
paraoxonase 2
PON2; paraoxonase 2; serum paraoxonase/arylesterase 2; PON 2; A-esterase 2; arylesterase 2; paraoxonase nirs; aromatic esterase 2; serum aryldialkylphosphatase 2;
TREX2
three prime repair exonuclease 2
TREX2; three prime repair exonuclease 2; 3-5 exonuclease TREX2 long form;
FOXO1
FOXO1 forkhead box O1
FOXO1; forkhead box O1; FKHR, forkhead homolog in rhabdomyosarcoma , FOXO1A; forkhead box protein O1; FKH1; forkhead box protein O1A; forkhead, Drosophila, homolog of, in rhabdomyosarcoma; FKHR; FOXO1A;
FOXO4
FOXO4 forkhead box O4
FOXO4; forkhead box O4; MLLT7, myeloid/lymphoid or mixed lineage leukemia (trithorax (Drosophila) homolog); translocated to, 7 , myeloid/lymphoid or mixed lineage leukemia (trithorax homolog, Drosophila); translocated to, 7; forkhead box protein O4; AFX1; fork head domain transcription factor AFX1; myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 7; AFX; MLLT7; MGC120490;
BBOX1
butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1
BBOX1; butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1; BBOX; gamma-butyrobetaine dioxygenase; BBH; G BBH; gamma BBH; gamma-butyrobetaine hydroxylase; gamma-butyrobetaine,2-oxoglutarate dioxygenase 1; G-BBH; gamma-BBH;
DNAI2
dynein, axonemal, intermediate chain 2
DNAI2; dynein, axonemal, intermediate chain 2; dynein, axonemal, intermediate polypeptide 2; dynein intermediate chain 2, axonemal; dynein intermediate chain 2; axonemal; Axonemal dynein intermediate chain 2; CILD9; DNAI 2; DNAI2_HUMAN; Dynein axonemal intermediate chain 2; Dynein axonemal intermediate polypeptide 2; Dynein intermediate chain 2 axonemal;
EXO1
exonuclease 1
EXO1; exonuclease 1; Exo 1; Exo I; EXO1_HUMAN; ExoI; Exonuclease I; Exonuclease1; ExonucleaseI; HEX 1; HEX1; hExo 1; hExo I; hExo1; hExoI; Rad2 nuclease family member homolog of S. cerevisiae exonuclease 1; mExo1; Msa; 5730442G03Rik;
EXOC3
exocyst complex component 3
EXOC3; exocyst complex component 3; SEC6 like 1 (S. cerevisiae) , SEC6L1; Sec6p; EXOC 3; Exocyst complex component Sec 6; Exocyst complex component Sec6; rSec 6; Sec 6; Sec 6 homolog; Sec 6p; Sec6; SEC6 L1; SEC6 like 1; Sec6 protein; SEC6L1; SEC6-like 1;
EXOC4
exocyst complex component 4
EXOC4; exocyst complex component 4; SEC8 like 1 (S. cerevisiae) , SEC8L1; KIAA1699; MGC27170; REC8; SEC8; Sec8p; dSec8; EXOC 4; EXOC4_HUMAN; Exocyst complex component Sec8; REC 8; rSec 8; Sec 8; Sec 8p; SEC8 like 1; SEC8 protein; Sec8L1; SEC8-like 1;
EXOC7
exocyst complex component 7
EXOC7; exocyst complex component 7; EXO70; Exo70p; KIAA1067; YJL085W; exocyst complex component Exo70; EX070; EXOC1; 2-5-3p; FLJ40965; FLJ46415; DKFZp686J04253;
EXOSC2
exosome component 2
EXOSC2; exosome component 2; exosome complex component RRP4; homolog of yeast RRP4 (ribosomal RNA processing 4); 3 5 exoribonuclease (RRP4); hRrp4p; p7; RRP4; Rrp4p; Exosome complex exonuclease RRP4; Homolog of yeast RRP4 (ribosomal RNA processing 4), 3 5 exoribonuclease (RRP4); Homolog of yeast RRP4 (ribosomal RNA processing 4), 3-5-exoribonuclease; OTTHUMP00000022370; OTTHUMP00000022371; OTTHUMP00000022372; OTTHUMP00000022373; OTTHUMP00000022374; Ribosomal RNA processing protein 4; Ribosomal RNA- processing protein 4; ribosomal RNA-processing protein 4; homolog of yeast RRP4 (ribosomal RNA processing 4), 3-5-exori;
EXOSC3
exosome component 3
EXOSC3; exosome component 3; exosome complex component RRP40; CGI 102; CGI 102 protein; exosome component Rrp40; hRrp 40; hRrp40p; p10; RRP40; Rrp40p; exosome complex exonuclease RRP40; ribosomal RNA-processing protein 40; CGI-102; hRrp-40; bA3J10.7; MGC7;
EXOSC5
exosome component 5
EXOSC5; exosome component 5; exosome complex component RRP46; exosome component Rrp46; hRrp46p; MGC12901; p12B; RRP41B; RRP46; Rrp46p; Chronic myelogenous leukemia tumor antigen 28; Ribosomal RNA processing protein 46; CML28; EXOSC 5; exosome complex exonuclease RRP46; ribosomal RNA-processing protein 46;
EXOSC8
exosome component 8
EXOSC8; exosome component 8; exosome complex component RRP43; bA421P11.3; CBP interacting protein 3; CIP3; EAP2; OIP2; Opa interacting protein 2; p9; RRP43; Rrp43p; OIP-2; CBP-interacting protein 3; opa-interacting protein 2; exosome complex exonuclease R;
EXT2
exostosin 2
EXT2; exostosin 2; exostoses (multiple) 2; exostosin-2; Glucuronosyl N acetylglucosaminyl proteoglycan 4 alpha N acetylglucosaminyltransferase; N acetylglucosaminyl proteoglycan 4 beta glucuronosyltransferase; SOTV; multiple exostoses protein 2; putative tumor suppressor protein EXT2; N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase; glucuronosyl-N-acetylglucosaminyl-proteoglycan/N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase;
HEXA
hexosaminidase A (alpha polypeptide)
HEXA; hexosaminidase A (alpha polypeptide); beta-hexosaminidase subunit alpha; GM2 gangliosidosis; Tay Sachs disease; Beta hexosaminidase alpha chain precursor; Beta hexosaminidase subunit alpha; Beta N acetylhexosaminidase; Beta N acetylhexosaminidase subunit alpha; Beta-N-acetylhexosaminidase subunit alpha; HEXA_HUMAN; Hexosaminidase A alpha polypeptide; Hexosaminidase A; Hexosaminidase subunit A; MGC99608; N acetyl beta glucosaminidase; N acetyl beta glucosaminidase subunit alpha; N-acetyl-beta-glucosaminidase subunit alpha; TSD;
ISG20
interferon stimulated exonuclease gene 20kDa
ISG20; interferon stimulated exonuclease gene 20kDa; interferon stimulated gene (20kD); interferon-stimulated gene 20 kDa protein; CD25; HEM45; Estrogen regulated transcript 45 protein; Interferon stimulated gene 20 kDa protein; Promyelocytic leukemia nuclear body associated protein; OTTHUMP00000192918; estrogen-regulated transcript 45 protein; promyelocytic leukemia nuclear body-associated protein ISG20;
ROBO1
roundabout, axon guidance receptor, homolog 1 (Drosophila)
ROBO1; roundabout, axon guidance receptor, homolog 1 (Drosophila); SAX3; DUTT1; roundabout homolog 1; deleted in U twenty twenty;
ROBO2
roundabout, axon guidance receptor, homolog 2 (Drosophila)
ROBO2; roundabout, axon guidance receptor, homolog 2 (Drosophila); SAX3; roundabout homolog 2;
SLC25A11
solute carrier family 25 (mitochondrial carrier; oxoglutarate carrier), member 11
SLC25A11; solute carrier family 25 (mitochondrial carrier; oxoglutarate carrier), member 11; SLC20A4; mitochondrial 2-oxoglutarate/malate carrier protein; OGC; OGCP; solute carrier family 25 member 11; solute carrier family 20 (oxoglutarate carrier), memb;
PON3
paraoxonase 3
PON3; paraoxonase 3; serum paraoxonase/lactonase 3; paraoxanase-3; arylesterase 3;
MX1
myxovirus (influenza virus) resistance 1, interferon-inducible protein p78 (mouse)
MX1; myxovirus (influenza virus) resistance 1, interferon-inducible protein p78 (mouse); myxovirus (influenza) resistance 1, homolog of murine (interferon inducible protein p78); interferon-induced GTP-binding protein Mx1; IFI 78K; MxA; N-terminally processed; Human interferon regulated resistance GTP binding protein MXA; IFI 78; IFI-78K; IFI78; IFI78K; Interferon induced GTP binding protein Mx1; Interferon induced protein p78; Interferon inducible protein p78; Interferon regulated resistance GTP binding protein; Interferon regulated resistance GTP binding protein MxA; Interferon-induced protein p78; Interferon-regulated resistance GTP-binding protein MxA; MX 1; MX; MX1_HUMAN; Myxoma resistance protein 1; Myxovirus (influenza virus) resistance 1 interferon inducible; Myxovirus (influenza virus) resistance 1 interferon inducible protein p78; Myxovirus (influenza) resistance 1 homolog of murine; Myxovirus resistance protein 1;
EXD1
exonuclease 3-5 domain containing 1
EXD1; exonuclease 3-5 domain containing 1; EXDL1, exonuclease 3 5 domain like 1; exonuclease 3-5 domain-containing protein 1; MGC33637; EXD1_HUMAN; exonuclease 3 5 domain like 1; Exonuclease 3-5 domain-like-containing protein 1; OTTHUMP00000160721; exonuclease 3-5 domain-like 1; EXDL1;
OGFOD1
2-oxoglutarate and iron-dependent oxygenase domain containing 1
OGFOD1; 2-oxoglutarate and iron-dependent oxygenase domain containing 1; 2-oxoglutarate and iron-dependent oxygenase domain-containing protein 1; FLJ10826; KIAA1612; TPA1; termination and polyadenylation 1; homolog (S. cerevisiae); 2 oxoglutarate and iron dependent oxygenase domain containing 1; OGFD1_HUMAN; Termination and polyadenylation 1 homolog; TPA1 termination and polyadenylation 1 homolog; TPA1, termination and polyadenylation 1, homolog;
ROBO4
roundabout, axon guidance receptor, homolog 4
ROBO4; roundabout, axon guidance receptor, homolog 4 (Drosophila); roundabout homolog 4 (Drosophila); roundabout homolog 4; ECSM4; FLJ20798; magic roundabout; MRB; roundabout homolog 4, magic roundabout; MGC133352; MGC133353;
DNALI1
dynein, axonemal, light intermediate chain 1
DNALI1; dynein, axonemal, light intermediate chain 1; dynein, axonemal, light intermediate polypeptide 1; axonemal dynein light intermediate polypeptide 1; dJ423B22.5; dJ423B22.5 (axonemal dynein light chain (hp28)); hp28; inner dynein arm; homolog of clamydomonas; P28; Axonemal dynein light chain (hp28); Axonemal dynein light chain; DNALI 1; Dynein axonemal light intermediate chain 1; Dynein axonemal light intermediate polypeptide 1; Inner dynein arm homolog of clamydomonas; Inner dynein arm light chain axonemal; OTTHUMP00000004400; inner dynein arm light chain, axonemal; inner dynein arm, homolog of clamydomonas;
EXOSC1
exosome component 1
EXOSC1; exosome component 1; exosome complex component CSL4; CGI 108; CSL4; CSL4 exosomal core protein homolog (yeast); Csl4p; hCsl4p; p13; SKI4; Ski4p; RP11-452K12.9; 3-5 exoribonuclease CSL4 homolog; exosomal core protein CSL4; CSL4 exosomal core protein homolog; homolog of yeast exosomal core protein CSL4; CGI-108;
EXOSC4
exosome component 4
EXOSC4;exosome component 4;exosome complex component RRP41;exosome component Rrp41;FLJ20591;hRrp41p;p12A;RRP41;RRP41A;Rrp41p;SKI6;Ski6p;exosome complex exonuclease RRP41;ribosomal RNA-processing protein 41;
EXOSC7
exosome component 7
EXOSC7; exosome component 7; exosome complex component RRP42; EAP1; hRrp42p; KIAA0116; p8; RRP42; Rrp42p; Exosome complex exonuclease RRP42; Ribosomal RNA processing protein 42; OTTHUMP00000164126; ribosomal RNA-processing protein 42;
REXO2
REX2, RNA exonuclease 2 homolog (S. cerevisiae)
REXO2; REX2, RNA exonuclease 2 homolog (S. cerevisiae); oligoribonuclease, mitochondrial; CGI 114; DKFZP566E144; SFN; 1810038D15Rik; AW107347; MGC105914; MGC111570; Oligoribonuclease, mitochondrial [Precursor]; RFN; RNA exonuclease 2 homolog; Small fragment nuclease; Smfn; REX2; CGI-114;
ROBO3
roundabout, axon guidance receptor, homolog 3 (Drosophila)
ROBO3; roundabout, axon guidance receptor, homolog 3 (Drosophila); HGPPS, horizontal gaze palsy with progressive scoliosis , roundabout (axon guidance receptor, Drosophila) homolog 3; roundabout homolog 3; FLJ21044; HGPS; RBIG1; HGPPS; RB inhibiting gene 1; Rbig 1; Retinoblastoma inhibiting gene 1; Rig 1; Rig1; Robo 3; Robo3 protein; Roundabout axon guidance receptor homolog 3; Roundabout like protein 3; roundabout-like protein 3;
SLC25A21
solute carrier family 25 (mitochondrial oxoadipate carrier), member 21
SLC25A21; solute carrier family 25 (mitochondrial oxoadipate carrier), member 21; solute carrier family 25 (mitochondrial oxodicarboxylate carrier), member 21; mitochondrial 2-oxodicarboxylate carrier; ODC; ODC1; oxodicarboxylate carrier; solute carrier f;
SRD5A2
steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2)
SRD5A2; steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2); 3-oxo-5-alpha-steroid 4-dehydrogenase 2; 5 alpha SR2; 3 oxo 5 alpha steroid 4 dehydrogenase 2; 5 alpha-SR2; 5ART2; e II 5 alpha reductase; EC; MGC138457; Micropenis, included; S5A2_HUMAN; S5AR 2; SR type 2; Steroid 5 alpha reductase 2; Steroid 5-alpha-reductase 2; Type II 5-alpha reductase; 3-oxo-5 alpha-steroid 4-dehydrogenase 2;
TREX1
three prime repair exonuclease 1
TREX1; three prime repair exonuclease 1; AGS1, Aicardi Goutieres syndrome 1; DRN3; DNase III; 3 repair exonuclease 1; 3-5 exonuclease TREX1; CRV; AGS1; HERNS; DKFZp434J0310;
HKDC1
hexokinase domain containing 1
HKDC1;hexokinase domain containing 1;FLJ22761;FLJ37767;Q2TB90;MGC125688;OTTHUMP00000019718;putative hexokinase HKDC1;Hexokinase domain-containing protein 1;EC 2.7.1;EC 2.7.1.1;
REXO1
REX1, RNA exonuclease 1 homolog
REXO1; REX1, RNA exonuclease 1 homolog (S. cerevisiae); TCEB3BP1, transcription elongation factor B polypeptide 3 binding protein 1; RNA exonuclease 1 homolog; EloA BP1; elongin A binding protein 1; KIAA1138; elongin A-binding protein 1; elongin-A-bindin;
DNAH9
dynein, axonemal, heavy chain 9
DNAH9; dynein, axonemal, heavy chain 9; DNAH17L, dynein, axonemal, heavy polypeptide 9 , dynein, axonemal, heavy polypeptide 17 like; dynein heavy chain 9, axonemal; Dnahc9; DNAL1; DYH9; HL 20; HL20; KIAA0357; DNAH9 variant protein; ciliary dynein heavy;
ERI1
exoribonuclease 1
ERI1; exoribonuclease 1; 3-5 exoribonuclease 1; eri-1 homolog; 3-5 exonuclease ERI1; enhanced RNAi protein 1; histone mRNA 3-exonuclease 1; three prime histone mRNA exonuclease 1; histone mRNA 3 end-specific exonuclease; Thex1; eri-1; 3hexo; 3110010F15Rik;
EXOSC9
exosome component 9
EXOSC9; exosome component 9; PMSCL1, polymyositis/scleroderma autoantigen 1, 75kDa; exosome complex component RRP45; p5; p6; PM/Scl 75; polymyositis/scleroderma autoantigen 1 (75kD); RRP45; Rrp45p; autoantigen PM/Scl 1; PMSCL autoantigen, 75kD; exosome c;
OGDH
oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide)
OGDH; oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide); 2-oxoglutarate dehydrogenase, mitochondrial; E1k; OGDC-E1; oxoglutarate decarboxylase; 2-oxoglutarate dehydrogenase complex component E1; oxoglutarate dehydrogenase (succinyl-transferring;
RIMS2
regulating synaptic membrane exocytosis 2
RIMS2; regulating synaptic membrane exocytosis 2; RAB3 interacting protein 3 , RAB3IP3; regulating synaptic membrane exocytosis protein 2; KIAA0751; OBOE; RIM2; RIM 2; nuclear protein; RAB3 interacting protein 3; rab-3-interacting protein 3; rab3-interact;
HEXB
hexosaminidase B (beta polypeptide)
HEXB; hexosaminidase B (beta polypeptide); beta-hexosaminidase subunit beta; Beta hexosaminidase beta chain; Beta N acetylhexosaminidase; Beta-hexosaminidase subunit beta chain A; Beta-N-acetylhexosaminidase subunit beta; Cervical cancer proto oncogene 7 protein; Cervical cancer proto-oncogene 7 protein; ENC 1AS; HCC 7; HCC-7; HCC7; HEX B; HEXB_HUMAN; Hexosaminidase B; Hexosaminidase subunit B; HexosaminidaseB; N acetyl beta glucosaminidase; N-acetyl-beta-glucosaminidase subunit beta; ENC-1AS;
MX2
myxovirus (influenza virus) resistance 2 (mouse)
MX2; myxovirus (influenza virus) resistance 2 (mouse); myxovirus (influenza) resistance 2, homolog of murine; interferon-induced GTP-binding protein Mx2; interferon regulated resistance GTP binding protein MXB; MXB; second interferon induced protein p78; Interferon induced GTP binding protein Mx2; Interferon-regulated resistance GTP-binding protein MxB; MX 2; MX2_HUMAN; Myxovirus (influenza virus) resistance 2; Myxovirus resistance 2; Myxovirus resistance protein 2; p78 related protein; p78-related protein; second interferon-induced protein p78;
OXCT1
3-oxoacid CoA transferase 1
OXCT1; 3-oxoacid CoA transferase 1; 3 oxoacid CoA transferase , OXCT; succinyl-CoA:3-ketoacid-coenzyme A transferase 1, mitochondrial; SCOT; 3 oxoacid CoA transferase 1; 3-oxoacid-CoA transferase 1; EC 2.8.3.5; OTTHUMP00000120012; OTTHUMP00000221550; OXCT; Scot S; Scot-S; SCOT1_HUMAN; Somatic type succinyl CoA:3 oxoacid CoA transferase; Somatic-type succinyl-CoA:3-oxoacid-CoA-transferase; Succinyl CoA:3 ketoacid CoA transferase; Succinyl CoA:3 ketoacid coenzyme A transferase 1 mitochondrial; Succinyl CoA:3 oxoacid CoA transferase; succinyl CoA:3-oxoacid CoA transferase; succinyl-CoA:3-ketoacid-CoA transferase; somatic-type succinyl CoA:3-oxoacid CoA-transferase;
PLOD2
procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2
PLOD2; procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2; procollagen lysine, 2 oxoglutarate 5 dioxygenase (lysine hydroxylase) 2; procollagen-lysine,2-oxoglutarate 5-dioxygenase 2; LH2; lysyl hydroxlase 2; 2-oxoglutarate 5-dioxygenase 2; Lysine hydroxylase 2; Lysyl hydroxylase 2; OTTHUMP00000215204; OTTHUMP00000215205; OTTHUMP00000215206; PLOD 2; PLOD2_HUMAN; Procollagen lysine 2 oxoglutarate 5 dioxygenase 2; Procollagen-lysine; Telopeptide lysyl hydroxylase; TLH;
EXOC2
exocyst complex component 2
EXOC2; exocyst complex component 2; SEC5 like 1 (S. cerevisiae) , SEC5L1; FLJ11026; Sec5p; SEC5-like 1; exocyst complex component Sec5; SEC5; SEC5L1;
AXDND1
axonemal dynein light chain domain containing 1
AXDND1; axonemal dynein light chain domain containing 1; C1orf125, chromosome 1 open reading frame 125; axonemal dynein light chain domain-containing protein 1; FLJ32940; FLJ25438; C1orf125; CA125_HUMAN; DKFZp686H1423; hypothetical protein LOC126859; RP11-215I23.2; Uncharacterized protein C1orf125;
DNAAF2
dynein, axonemal, assembly factor 2
DNAAF2; dynein, axonemal, assembly factor 2; C14orf104, chromosome 14 open reading frame 104; protein kintoun; FLJ10563; kintoun; KTU; Chromosome 14 open reading frame 104; CILD10; KTU_HUMAN; dynein assembly factor 2, axonemal; C14orf104;
CHRFAM7A
CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion
CHRFAM7A; CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion; CHRNA7-FAM7A fusion protein; CHRNA7 DR1; D 10; Alpha 7 neuronal nicotinic acetylcholine receptor FAM7A hybrid; CHRNA7 (cholinergic receptor nicotinic alpha 7 exons 5 10) and FAM7A (family with sequence similarity 7A exons A E) fusion; CHRNA7; CHRNA7 FAM7A fusion; CHRNA7 FAM7A fusion protein; D10; HGNC:15781; MGC120482; MGC120483; alpha-7 nicotinic cholinergic receptor subunit; alpha 7 neuronal nicotinic acetylcholine receptor-FAM7A hybrid; CHRNA7 (cholinergic receptor, nicotinic, alpha polypeptide 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion; D-10; CHRNA7-DR1;
EXTL2
exostoses (multiple)-like 2
EXTL2; exostoses (multiple)-like 2; exostosin-like 2; alpha 1; 4 N acteylhexosaminyltransferase; Alpha 1 4 N acetylhexosaminyltransferase EXTL2; Alpha GalNAcT EXTL2; Exostoses (multiple) like 2; Exostoses multiple like 2; Exostosin like 2; EXT L2; EXT related protein 2; EXTL 2; EXTR 2; EXTR2; Glucuronyl galactosyl proteoglycan 4 alpha N acetylglucosaminyltransferase; Multiple exostoses like 2; Processed exostosin like 2; alpha-GalNAcT EXTL2; EXT-related protein 2; processed exostosin-like 2; alpha-1,4-N-acteylhexosaminyltransferase; alpha-1,4-N-acetylhexosaminyltransferase EXTL2; glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase;
EXTL3
exostoses (multiple)-like 3
EXTL3; exostoses (multiple)-like 3; exostosin-like 3; botv; REG receptor; REGR; EXT-related protein 1; multiple exostosis-like protein 3; putative tumor suppressor protein EXTL3; hereditary multiple exostoses gene isolog; glucuronyl-galactos;
DLST
dihydrolipoamide S-succinyltransferase (E2 component of 2-oxo-glutarate complex)
DLST; dihydrolipoamide S-succinyltransferase (E2 component of 2-oxo-glutarate complex); DLTS; dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex, mitochondrial; E2K; OGDC-E2;
GCKR
glucokinase (hexokinase 4) regulator
GCKR; glucokinase (hexokinase 4) regulator; GKRP; FGQTL5; glucokinase regulatory protein;
EXOG
endo/exonuclease (5-3), endonuclease G-like
EXOG; endo/exonuclease (5-3), endonuclease G-like; ENDOGL1, ENDOGL2, endonuclease G like 1 , endonuclease G like 2; nuclease EXOG, mitochondrial; ENGL; ENGL a; ENGL b; endo G-like 1; endonuclease G-like 1; endonuclease G-like 2; ENGLA; ENGLB; ENGL-a; EN;
HEXDC
hexosaminidase (glycosyl hydrolase family 20, catalytic domain) containing
HEXDC; hexosaminidase (glycosyl hydrolase family 20, catalytic domain) containing; hexosaminidase D; FLJ23825; Beta hexosaminidase D; Beta N acetylhexosaminidase; Hexosaminidase (glycosyl hydrolase family 20 catalytic domain) containing; Hexosaminidase domain containing protein; N acetyl beta galactosaminidase; beta-hexosaminidase D; beta-N-acetylhexosaminidase; N-acetyl-beta-galactosaminidase; hexosaminidase domain-containing protein;
EXPH5
exophilin 5
EXPH5; exophilin 5; exophilin-5; SLAC2 B; synaptotagmin like homologue lacking C2 domains b; MGC134967; DKFZp586F1223; DKFZp781H0795; Exophilin5; KIAA0624; MGC133291; SLAC2-B; SLAC2B; slp homolog lacking C2 domains b; synaptotagmin-like homologue lacking C2 domains b; synaptotagmin-like protein homolog lacking C2 domains b;
EXOC1
exocyst complex component 1
EXOC1; exocyst complex component 1; SEC3 like 1 (S. cerevisiae) , SEC3L1; BM 102; FLJ10893; SEC3; Sec3p; BM-012; EXOC1_HUMAN; Exocyst complex component Sec3; SEC3 like 1; SEC3L1; SEC3-like 1; BM-102;
EXOC3L2
exocyst complex component 3-like 2
EXOC3L2; exocyst complex component 3-like 2; exocyst complex component 3-like protein 2; FLJ36147; XTP7; HBV XAg-transactivated protein 7; HBV X-transactivated gene 7 protein; protein 7 transactivated by hepatitis B virus X antigen (HBxAg); MGC16332;
EXOC5
exocyst complex component 5
EXOC5; exocyst complex component 5; SEC10 (S. cerevisiae) like 1 , SEC10 like 1 (S. cerevisiae) , SEC10L1; SEC10; SEC10P; AI448003; Gm76; HSEC10; PRO1912; AI447711; Exocyst complex component Sec10; p71 component of rsec6/8 secretory complex; SEC10L1; SEC10-like 1;
EXOC6
exocyst complex component 6
EXOC6; exocyst complex component 6; SEC15 like 1 (S. cerevisiae) , SEC15L1; DKFZp761I2124; EXOC6A; FLJ1125; MGC33397; SEC15L; Sec15p; SEC15-like 1; SEC15-like protein 1; SEC15-like protein 3; exocyst complex component Sec15A; SEC15; SEC15L1; SEC15L3; FLJ1;
EXOC6B
exocyst complex component 6B
EXOC6B; exocyst complex component 6B; SEC15 homolog B (S. cerevisiae) , SEC15 like 2 (S. cerevisiae) , SEC15B, SEC15L2; KIAA0919; EXC6B_HUMAN; Exocyst complex component Sec15B; SEC15-like protein 2; SEC15B; SEC15L2; SEC15-like 2; SEC15 homolog B; WUGSC:H_NH0343N14.1;
EXOC8
exocyst complex component 8
EXOC8; exocyst complex component 8; EXO84; Exo84p; SEC84; exocyst complex 84 kDa subunit; exocyst complex 84-kDa subunit;
ERI2
ERI1 exoribonuclease family member 2
ERI2; ERI1 exoribonuclease family member 2; EXOD1, exonuclease domain containing 1; ERI1 exoribonuclease 2; enhanced RNAi three prime mRNA exonuclease homolog 2 (C.elegans); exoribonuclease 2; KIAA1504; MGC16943; EXOD 1; EXOD1; Exonuclease domain containing 1; Exonuclease domain containing protein 1; similar to RIKEN cDNA 4933424N09 gene; exonuclease domain-containing protein 1; enhanced RNAi three prime mRNA exonuclease homolog 2;
LOC81691
exonuclease NEF-sp
LOC81691; exonuclease NEF-sp; putative RNA exonuclease NEF-sp; Putative RNA exonuclease NEF sp;
OPLAH
5-oxoprolinase (ATP-hydrolysing)
OPLAH; 5-oxoprolinase (ATP-hydrolysing); 5-oxoprolinase; 5 Opase; OPLA; 5 oxo L prolinase; 5 oxoprolinase (ATP hydrolysing); 5 oxoprolinase; DKFZp434H244; Pyroglutamase; 5-oxo-L-prolinase; 5-Opase;
PAOX
polyamine oxidase (exo-N4-amino)
PAOX; polyamine oxidase (exo-N4-amino); polyamine oxidase; PAO; DKFZp434J245; MGC45464; Peroxisomal N(1) acetyl spermine/spermidine oxidase; Peroxisomal N1 acetyl spermine/spermidine oxidase; Polyamine oxidase (exo N4 amino); RP11 122K13.11; peroxisomal N1-acetyl-spermine/spermidine oxidase;
PLOD3
procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3
PLOD3; procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3; procollagen-lysine,2-oxoglutarate 5-dioxygenase 3; LH3; lysyl hydroxlase 3; 2-oxoglutarate 5-dioxygenase 3; Lysine hydroxylase 3; Lysyl hydroxylase 3; PLOD3_HUMAN; Procollagen lysine,2 oxoglutarate 5 dioxygenase 3 precursor; Procollagen-lysine;
OXCT2
3-oxoacid CoA transferase 2
OXCT2; 3-oxoacid CoA transferase 2; succinyl-CoA:3-ketoacid-coenzyme A transferase 2, mitochondrial; FKSG25; FLJ00030; SCOT T; 3 oxoacid CoA transferase 2; SCOTT; Succinyl CoA:3 ketoacid coenzyme A transferase 2, mitochondrial; Testis specific succinyl CoA:3 oxoacid CoA transferase; 3-oxoacid-CoA transferase 2A; testis-specific succinyl CoA:3-oxoacid CoA-transferase; testis-specific succinyl-CoA:3-oxoacid CoA-transferase;
RIMS1
regulating synaptic membrane exocytosis 1
RIMS1; regulating synaptic membrane exocytosis 1; CORD7, RAB3 interacting protein 2 , RAB3IP2; regulating synaptic membrane exocytosis protein 1; KIAA0340; Rab3 interacting molecule; RIM; RIM1; RAB3-interacting protein 2; rab-3-interacting protein 2; rab;
RIMS4
regulating synaptic membrane exocytosis 4
RIMS4; regulating synaptic membrane exocytosis 4; C20orf190, chromosome 20 open reading frame 190; regulating synaptic membrane exocytosis protein 4; dJ781B1.3; C20orf190; Rab3-interacting molecule 4; RIM 4; RIM4 gamma; RIMS4_HUMAN; RIM4; RIM-4; RIM4gamma; RIM4-gamma;
SAX
saxophone
SAX; saxophone; CG1891 gene product from transcript CG1891-RA; CG1891; receptor protein serine/threonine kinase; X linked surface antigen; saxophone, isoform A; CG1891-PA; sax-PA; saxophone, isoform B; CG1891-PB; sax-PB; Bkr43E; Brk43E; Dmel\CG1891; STK-B;
speC
Streptococcal Pyrogenic Exotoxin C
SPEC; Exotoxin C; Exotoxin C precursor; Exotoxin type C; Spe C; Eubacteria; Firmicutes; Cocci; Lactobacillales; Streptococcaceae; Streptococcus; S. pyogenes; Streptococcus pyogenes;
SRD5A1
steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1)
SRD5A1; steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1); 3-oxo-5-alpha-steroid 4-dehydrogenase 1; S5AR; SR type 1; 3 oxo 5 alpha steroid 4 dehydrogenase 1; 3 Oxo 5 alpha steroid delta 4 dehydrogenase alpha 1; 3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1,5-alpha reductase; 5 alpha reductase; S5A1_HUMAN; S5AR 1; SRD5A 1; Steroid 5 alpha reductase 1; Steroid 5 alpha reductase alpha polypeptide 1 (3 oxo 5 alpha steroid delta 4 dehydrogenase alpha 1); Steroid 5 alpha reductase alpha polypeptide 1; Steroid 5 alpha reductase type I; Steroid 5-alpha-reductase 1; 5-alpha reductase; steroid 5-alpha-reductase type I; 3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1;
XRN2
5-3 exoribonuclease 2
XRN2; 5-3 exoribonuclease 2; DHP protein; Dhm1-like protein (mouse homolog);
XRN1
5"-3" exoribonuclease 1
XRN1; 5"-3" exoribonuclease 1; SEP1; Strand-exchange protein 1 homolog; FLJ41903; DKFZp434P0721; DKFZp686B22225; DKFZp686F19113; OTTHUMP00000214507; OTTHUMP00000214577; OTTHUMP00000214578; EC 3.1.11;
OXER1
oxoeicosanoid (OXE) receptor 1
OXER1; oxoeicosanoid (OXE) receptor 1; oxoeicosanoid receptor 1; 5 oxo ETE acid G protein coupled receptor 1; GPCR; GPR170; TG1019; G-protein coupled receptor 170; G-protein coupled receptor R527; G-protein coupled receptor TG1019; 5-oxo-ETE G-protein cou;
EXOSC6
exosome component 6
EXOSC6; exosome component 6; exosome complex component MTR3; EAP4; hMtr3p; MTR3; Mtr3 (mRNA transport regulator 3) homolog (yeast); Mtr3p; p11; hMtr3; homolog of yeast mRNA transport regulator 3; Mtr3 (mRNA transport regulator 3)-homolog; exosome complex exonuclease MTR3; mRNA transport regulator 3 homolog;
DNAAF1
dynein, axonemal, assembly factor 1
DNAAF1; dynein, axonemal, assembly factor 1; leucine rich repeat containing 50 , LRRC50; dynein assembly factor 1, axonemal; CILD13; FLJ25330; ODA7; outer row dynein assembly 7 homolog (Chlamydomonas); leucine rich repeat containing 50; outer row dynein a;
OXGR1
oxoglutarate (alpha-ketoglutarate) receptor 1
OXGR1; oxoglutarate (alpha-ketoglutarate) receptor 1; G protein coupled receptor 80 , GPR80, GPR99; 2-oxoglutarate receptor 1; P2RY15; P2Y15; P2Y-like GPCR; P2Y purinoceptor 15; oxoglutarate receptor 1; P2Y-like nucleotide receptor; G protein-coupled rece;
ISG20L2
interferon stimulated exonuclease gene 20kDa-like 2
ISG20L2;interferon stimulated exonuclease gene 20kDa-like 2;25745;ENSG00000143319;1q23.1;FLJ12671;interferon-stimulated 20 kDa exonuclease-like 2;interferon-stimulated 20 kDa exonuclease-like 2;
NXPH2
neurexophilin 2
NXPH2;neurexophilin 2;8076;ENSG00000144227;NPH2;2q22.1;MGC125477, MGC125478, MGC125479, MGC125480;neurexophilin-2;neurexophilin-2;
RIMS3
regulating synaptic membrane exocytosis 3
RIMS3;regulating synaptic membrane exocytosis 3;21292;ENSG00000117016;NIM3;RIM3;1pter-p22.2;KIAA0237;regulating synaptic membrane exocytosis protein 3;regulating synaptic membrane exocytosis protein 3;RIM 3;RIM3 gamma;Rab-3 interacting molecule 3;rab-3-interacting molecule 3;
FAXC
failed axon connections homolog (Drosophila)
FAXC;failed axon connections homolog (Drosophila);20742;ENSG00000146267;C6orf168;dJ273F20;6q16.2;MGC2817, FLJ30539;failed axon connections homolog;failed axon connections homolog;
DNAH1
dynein, axonemal, heavy chain 1
DNAH1;dynein, axonemal, heavy chain 1;2940;ENSG00000114841;HL11;HDHC7;HL-11;DNAHC1;XLHSRF-1;3p21.1;dynein heavy chain 1, axonemal;dynein heavy chain 1, axonemal;HSRF-1;DNAH1 variant protein;heat shock regulated 1;ciliary dynein heavy chain 1;heat shock regulated protein 1;axonemal beta dynein heavy chain 1;dynein, axonemal, heavy polypeptide 1;
DNAH10
dynein, axonemal, heavy chain 10
DNAH10;dynein, axonemal, heavy chain 10;2941;ENSG00000197653;12q24.31;FLJ38262, FLJ43486, FLJ43808, KIAA2017;dynein heavy chain 10, axonemal;dynein heavy chain 10, axonemal;ciliary dynein heavy chain 10;axonemal beta dynein heavy chain 10;dynein, axonemal, heavy polypeptide 10;
DNAH14
dynein, axonemal, heavy chain 14
DNAH14;dynein, axonemal, heavy chain 14;2945;ENSG00000185842;HL18;HL-18;C1orf67;Dnahc14;1q42.12;MGC27277, MGC51214, MGC149665, MGC149666, DKFZp781B1548;dynein heavy chain 14, axonemal;dynein heavy chain 14, axonemal;ciliary dynein heavy chain 14;axonemal beta dynein heavy chain 14;dynein, axonemal, heavy polypeptide 14;
DNAH6
dynein, axonemal, heavy chain 6
DNAH6;dynein, axonemal, heavy chain 6;2951;ENSG00000115423;HL2;HL-2;DNHL1;Dnahc6;2p11.2;FLJ23529, FLJ37357, KIAA1697, MGC132544, MGC141984, MGC177197, DKFZp667K087;dynein heavy chain 6, axonemal;dynein heavy chain 6, axonemal;dynein heavy chain-like 1;ciliary dynein heavy chain 6;axonemal beta dynein heavy chain 6;dynein, axonemal, heavy polypeptide 6;
DNAH7
dynein, axonemal, heavy chain 7
DNAH7;dynein, axonemal, heavy chain 7;18661;ENSG00000118997;2q32.3;FLJ37196, KIAA0944, MGC39580, DKFZp686C09101;dynein heavy chain 7, axonemal;dynein heavy chain 7, axonemal;hDHC2;ciliary dynein heavy chain 7;axonemal dynein heavy chain 7;dynein heavy chain-like protein 2;axonemal beta dynein heavy chain 7;dynein, axonemal, heavy polypeptide 7;
DNAH8
dynein, axonemal, heavy chain 8
DNAH8;dynein, axonemal, heavy chain 8;2952;ENSG00000124721;hdhc9;ATPase;6p21.2;FLJ25850, FLJ36115, FLJ36334;dynein heavy chain 8, axonemal;dynein heavy chain 8, axonemal;ciliary dynein heavy chain 8;axonemal beta dynein heavy chain 8;dynein, axonemal, heavy polypeptide 8;
DNAH12
dynein, axonemal, heavy chain 12
DNAH12;dynein, axonemal, heavy chain 12;2943;ENSG00000174844;DHC3;HL19;DLP12;DNHD2;HDHC3;HL-19;DNAH7L;DNAHC3;DNAH12L;DNAHC12;3p14.3;FLJ40427, FLJ44290;dynein heavy chain 12, axonemal;dynein heavy chain 12, axonemal;dynein, heavy chain-5;ciliary dynein heavy chain 12;axonemal beta dynein heavy chain 12;axonemal dynein heavy chain isotype3;dynein, axonemal, heavy chain 12-like;dynein, axonemal, heavy polypeptide 12;dynein heavy chain domain-containing protein 2;
ERI3
ERI1 exoribonuclease family member 3
ERI3;ERI1 exoribonuclease family member 3;17276;ENSG00000117419;PINT1;PRNPIP;1p32;MGC2683, FLJ22943;ERI1 exoribonuclease 3;ERI1 exoribonuclease 3;H_RG158K20.1;exoribonuclease 3;WUGSC:H_RG158K20.1;prion interactor 1;prion protein interacting protein;prion protein-interacting protein;enhanced RNAi three prime mRNA exonuclease homolog 3;
EXOC3L1
exocyst complex component 3-like 1
EXOC3L1;exocyst complex component 3-like 1;27540;ENSG00000179044;EXOC3L;16q22.1;FLJ35539, FLJ35587, MGC88052;exocyst complex component 3-like protein;exocyst complex component 3-like protein;protein Jiangli;
OXSM
3-oxoacyl-ACP synthase, mitochondrial
OXSM;3-oxoacyl-ACP synthase, mitochondrial;26063;ENSG00000151093;KS;KASI;FASN2D;3p24.2;FLJ20604;3-oxoacyl-[acyl-carrier-protein] synthase, mitochondrial;3-oxoacyl-[acyl-carrier-protein] synthase, mitochondrial;beta-ketoacyl synthase;beta-ketoacyl-ACP synthase;3-oxoacyl-acyl-carrier-protein synthase;3-ketoacyl-acyl carrier protein synthase;type II mitochondrial beta-ketoacyl synthase;acyl-malonyl acyl carrier protein-condensing enzyme;EC 2.3.1.41;
OGDHL
oxoglutarate dehydrogenase-like
OGDHL;oxoglutarate dehydrogenase-like;25590;ENSG00000197444;10q11.23;2-oxoglutarate dehydrogenase-like, mitochondrial;2-oxoglutarate dehydrogenase-like, mitochondrial;OGDC-E1-like;alpha-ketoglutarate dehydrogenase-like;2-oxoglutarate dehydrogenase complex component E1-like;EC 1.2.4.-;
Dnahc9
dynein, axonemal, heavy chain 9
DNAH9; mKIAA0357; 9030022M04; A230091C01; C230051G16; D11Ertd686e;
FAM55C
neurexophilin and PC-esterase domain family, member 3
Fam55c; NXPE3; neurexophilin and PC-esterase domain family, member 3; 28238; ENSG00000144815; MST115; MSTP115; 3q12.3; FLJ30102, MGC15606; protein FAM55C; family with sequence similarity 55, member C;
FAM55D
neurexophilin and PC-esterase domain family, member 4
FAM55D; C11orf33; NXPE4; neurexophilin and PC-esterase domain family, member 4; 23117; ENSG00000137634; 11q23.2; FLJ20127; protein FAM55D; family with sequence similarity 55, member D;
CXorf27
CXorf27 chromosome X open reading frame 27 [ Homo sapiens ]
1700054O13Rik; Chromosome X open reading frame 27; CXorf27; HIP17; Huntingtin interacting protein M; Huntingtin yeast partner M; Huntingtin-interacting protein M; HYPM; HYPM_HUMAN;
Dnal1
DNAL1 dynein, axonemal, light chain 1 [ Homo sapiens ]
axonemal; Axonemal dynein light chain 1; Axonemal dynein light chain; C14orf168; Chromosome 14 open reading frame 168; CILD16; DNAL 1; dnal1; DNAL1_HUMAN; Dynein axonemal light chain 1; Dynein light chain 1; Dynein light chain 1 axonemal; MGC12435;
Eepd1
EEPD1 endonuclease/exonuclease/phosphatase family domain containing 1 [ Homo sapiens ]
endonuclease/exonuclease/phosphatase family domain containing 1; 22223; Ensembl:ENSG00000122547; KIAA1706; endonuclease/exonuclease/phosphatase family domain-containing protein 1; HSPC107;
Exd2
EXD2 exonuclease 3-5 domain containing 2 [ Homo sapiens ]
exonuclease 3-5 domain containing 2; 20217; Ensembl:ENSG00000081177; FLJ10738, DKFZp781A0133, DKFZp781L15100; exonuclease 3-5 domain-containing protein 2; exonuclease 3-5 domain-like 2; exonuclease 3-5 domain-like-containing protein 2; EXDL2; C14orf114;
Extl1
EXTL1 exostoses (multiple)-like 1 [ Homo sapiens ]
exostoses (multiple)-like 1; 3515; Ensembl:ENSG00000158008; MGC70794; exostosin-like 1; exostosin-L; multiple exostosis-like protein; alpha-N-acetylglucosaminyltransferase II; glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase; glucuronyl-N-acetylglucosaminylproteoglycan alpha-1,4-N- acetylglucosaminyltransferase; glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N- acetylglucosaminyltransferase; 2.4.1.224; EXTL;
CXorf22
CXorf22 chromosome X open reading frame 22 [ Homo sapiens (human) ]
chromosome X open reading frame 22; CX022_HUMAN; CXorf22; MGC34831; Uncharacterized protein CXorf22;
NXPE1
NXPE1 neurexophilin and PC-esterase domain family, member 1 [ Homo sapiens ]
neurexophilin and PC-esterase domain family, member 1; 28527; Ensembl:ENSG00000095110; MGC34290; NXPE family member 1; protein FAM55A; family with sequence similarity 55, member A; FAM55A;
Exonuclease I
Exodeoxyribonuclease I
Exodeoxyribonuclease I; EC 3.1.11.1; Escherichia coli exonuclease I; E. coli exonuclease I; exonuclease I;
Soligenix Collaborates with Intrexon on Promoting Monoclonal Antibody Therapy for Melioidosis
On May 1, 2013, Soligenix, Inc., a biopharmaceutical company focused on developing products to treat inflammatory diseases and biodefense countermeasures announced its collaboration between Intrexon to develop a treatment for Melioidosis. Intrexon is a synthetic biology company that utilizes its...
GlaxoSmithKline’s Scientific Study Data was Questioned
There are always rumors and scandals. This time the scandal spread to scientific community and made GlaxoSmithKline (GSK) becoming the major topic of this week as a panel discusses the potential risks of the questioned drug. GSK, the London-based drug giant recently has co...
Immunocore Cooperates with GlaxoSmithKline to Target on Cancer and Viral Disease
On July 9, 2013, Immunocore announced that it has entered into a partnership with GlaxoSmithKlinefor multiple novel targets after signing the research and licensing agreement to discover and develop novel biological drugsImmune mobilising mTCR Against Cancer (ImmTACs) in earlier times. ...
